Transcatheter Valve Market Size, Emerging Trends and Overview to 2024: Hexa Reports

Submitted by: Submitted by

Views: 10

Words: 959

Pages: 4

Category: Business and Industry

Date Submitted: 10/03/2016 03:50 AM

Report This Essay

Hexa Reports

Market Research Reports and Insightful Company Profiles

Transcatheter Valve Market Analysis, Share and Size,

Emerging Trends, Growth, Overview And Segment

Forecasts To 2024

The global transcatheter valve market is anticipated to reach a value of USD 8.62 billion by 2024,

according to a new report by Grand View Research, Inc. The market is currently under-penetrated as

these products are approved only for geriatric patients who cannot undergo normal valve surgeries.

Growth drivers such as increasing prevalence of chronic cardiovascular diseases, increasing economic

development, improvement in reimbursement scenario, and faster adoption of new technologies are

expected to significantly improve the usage rates over the forecast period.

Browse Detail Report With TOC @

http://www.hexareports.com/report/transcatheter-valve-market/details

The transcatheter valve market is evolving rapidly due to the continuous investments in R&D by the key

market players such as Edwards Life Sciences, Medtronic, St. Jude, and Boston Scientific. The

technologically advanced products such as the SAPIEN 3 transcatheter heart valve and the TRINITY Valve

are designed to reduce the surgical complications and improve patient compliance. For instance, the

TRINITY TAVI system enables easy retrieval and repositioning of the device, without compromising on

patient safety and treatment outcomes.

Furthermore, the market is expected to experience strong tailwinds on account of growing investor

interest, lucrative product pipeline, faster regulatory approvals, and high competition to acquire

Hexa Reports

Market Research Reports and Insightful Company Profiles

potential start-ups. For example, some of the notable investments in the market include the USD 37

million funding of Venus MedTech by Goldman Sachs. In line with the market trends, the other market

participants such as Boston Scientific, Edward Life Sciences, and Medtronic have also increased their

investments to develop new...